FDA grants IND clearance for Allay’s trial of post-surgical pain treatment

FDA grants IND clearance for Allay’s trial of post-surgical pain treatment

Submitted by admin on June 13, 2024 - 10:52am
Source: 
Clinical Trials Arena
News Tags: 
Allay Therapeutics
FDA
ATX101
post-surgical pain
Headline: 
FDA grants IND clearance for Allay’s trial of post-surgical pain treatment
snippet: 

The US Food and Drug Administration (FDA) has granted clearance to Allay Therapeutics’ investigational new drug (IND) application to initiate a Phase IIb clinical trial of ATX101, aimed at alleviating post-surgical pain in patients undergoing total knee replacement surgery.

Do Not Allow Advertisers to Use My Personal information